S E Langabeer

Summary

Affiliation: University College London
Country: UK

Publications

  1. ncbi request reprint EVI1 expression in acute myeloid leukaemia
    S E Langabeer
    Department of Haematology, University College London Hospitals and Medical School, London, UK
    Br J Haematol 112:208-11. 2001
  2. ncbi request reprint The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United King
    P D Kottaridis
    Department of Haematology, University College London, London, United Kingdom
    Blood 98:1752-9. 2001
  3. ncbi request reprint Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia
    S E Langabeer
    Department of Haematology, University College London, London, UK
    Leukemia 16:393-9. 2002
  4. ncbi request reprint AML with t(8;21) and trisomy 4: possible involvement of c-kit?
    S E Langabeer
    Leukemia 17:1915; author reply 1915-6. 2003
  5. ncbi request reprint Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders
    S E Langabeer
    Cancer Molecular Diagnostics, Central Pathology Laboratory, St James s Hospital, Dublin 8, Ireland
    Ir J Med Sci 176:105-9. 2007

Detail Information

Publications5

  1. ncbi request reprint EVI1 expression in acute myeloid leukaemia
    S E Langabeer
    Department of Haematology, University College London Hospitals and Medical School, London, UK
    Br J Haematol 112:208-11. 2001
    ..This study nevertheless demonstrates that deregulation of EVI1, although rare in APL, is a relatively frequent event in AML...
  2. ncbi request reprint The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United King
    P D Kottaridis
    Department of Haematology, University College London, London, United Kingdom
    Blood 98:1752-9. 2001
    ..The suggestion is made that detection of a FLT3/ITD should be included as a routine test at diagnosis and evaluated for therapeutic management...
  3. ncbi request reprint Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia
    S E Langabeer
    Department of Haematology, University College London, London, UK
    Leukemia 16:393-9. 2002
    ..A BCR-ABL/ABL ratio of 0.01 served as a useful arbitrary indicator value, with results above and below this value generally correlating with relapse or remission, respectively...
  4. ncbi request reprint AML with t(8;21) and trisomy 4: possible involvement of c-kit?
    S E Langabeer
    Leukemia 17:1915; author reply 1915-6. 2003
  5. ncbi request reprint Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders
    S E Langabeer
    Cancer Molecular Diagnostics, Central Pathology Laboratory, St James s Hospital, Dublin 8, Ireland
    Ir J Med Sci 176:105-9. 2007
    ..The chronic myeloproliferative disorders (MPD) are clonal haemopoietic stem cell disorders...